Download PDF

Other users also viewed these articles

Efficacy and Safety of Baricitinib in Patients with Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic DMARDs and/or Biological DMARDs: Data from a Local Registry José Rosas; José Miguel Senabre-Gallego; Gregorio Santos-Soler; José Antonio Bernal; Ana Pons Bas;
Reumatol Clin. 2022;18:188-9
Experience With the Use of Baricitinib and Tocilizumab Monotherapy or Combined, in Patients With Interstitial Pneumonia Secondary to Coronavirus COVID19: A Real-World Study José Rosas; Francisco Pasquau Liaño; Mónica Llombart Cantó; José María Carrasco Barea; Amparo Raga Beser; José Tomás Algado Rabasa; Francisco Martínez Adsuar; Brian Vila Auli; Isabel Fernández López; Ana María Garijo Sainz; Pere Esquerdo Ramis; Laura Ruiz Pérez; Mª Luisa Navarrete Rebollo; Raquel Hernández Lorido; Laura Gómez Escolar;
Reumatol Clin. 2022;18:150-6
Organisational and clinical approach to osteoporosis in rheumatology: OP-SER-Excellence survey and consensus Antonio Naranjo; Pilar Aguado; Javier de Toro; M. Dolores Toledo; Teresa González; José Rosas; Cristina Campos Fernández; Diana Gavilan;
Reumatol Clin. 2021;17:322-8